We are live on ! Find out more
SCA

Stokes Capital Advisors Portfolio holdings

AUM $467M
1-Year Est. Return 14.84%
This Fund
S&P 500
This Quarter Est. Return
+2.21%
1 Year Est. Return
+14.84%
3 Year Est. Return
+54.54%
5 Year Est. Return
+73.74%
10 Year Est. Return
AUM
$294M
AUM Growth
+$4.1M
Cap. Flow
+$6.14K
Cap. Flow %
0%
Top 10 Hldgs %
27.41%
Holding
87
New
2
Increased
33
Reduced
36
Closed
6

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$2.56M
2
SYK icon
Stryker
SYK
+$1.73M
3
CL icon
Colgate-Palmolive
CL
+$1.36M
4
MA icon
Mastercard
MA
+$725K
5
UNH icon
UnitedHealth
UNH
+$605K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$3.32M
2
ROP icon
Roper Technologies
ROP
+$3.01M
3
ECL icon
Ecolab
ECL
+$557K
4
CASY icon
Casey's General Stores
CASY
+$526K
5
STE icon
Steris
STE
+$491K

Sector Composition

Rank Sector Weight
1 Industrials 14.39%
2 Technology 13.51%
3 Consumer Staples 12.07%
4 Financials 11.4%
5 Healthcare 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDS icon
76
Factset
FDS
$9.36B
$323K 0.11%
779
DUK icon
77
Duke Energy
DUK
$97.8B
$313K 0.11%
3,249
+138
+4% +$13.6K
ET icon
78
Energy Transfer Partners
ET
$70.1B
$310K 0.11%
24,846
OLN icon
79
Olin
OLN
$2.11B
$278K 0.09%
5,000
MMP
80
DELISTED
Magellan Midstream Partners, L.P.
MMP
$226K 0.08%
4,171
-850
-17% -$45K
ABBV icon
81
AbbVie
ABBV
$443B
$222K 0.08%
1,390
CASY icon
82
Casey's General Stores
CASY
$32.2B
-2,345
Closed -$526K
ECL icon
83
Ecolab
ECL
$78.1B
-3,824
Closed -$557K
IGSB icon
84
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
-4,064
Closed -$202K
OKE icon
85
Oneok
OKE
$57.2B
-3,495
Closed -$230K
PFE icon
86
Pfizer
PFE
$143B
-64,734
Closed -$3.32M
STE icon
87
Steris
STE
$22.3B
-2,660
Closed -$491K

Similar funds

Stokes Capital Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Stokes Capital Advisors held 87 positions worth $294M, up 1.4% from $290M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Stokes Capital Advisors's Q1 2023 filing shows 2 new, 33 increased, 36 reduced and 6 closed positions. Its largest new stake was American Tower: 12,190 shares worth $2.49M. The largest sale was Pfizer, an estimated $3.32M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Staples.

  • Stokes Capital Advisors's largest Q1 2023 buy was American Tower: 12,190 shares worth $2.49M.
  • Stokes Capital Advisors added most to Stryker in Q1 2023, an estimated $1.73M increase.
  • Stokes Capital Advisors's biggest Q1 2023 reduction was Roper Technologies, cutting an estimated $3.01M.
  • Stokes Capital Advisors fully exited Pfizer in Q1 2023, selling an estimated $3.32M.
  • Stokes Capital Advisors's ten largest holdings make up 27% of its $294M portfolio in Q1 2023.
  • Stokes Capital Advisors opened 2 new positions and closed 6 in Q1 2023.
  • Stokes Capital Advisors's portfolio value rose 1.4% quarter-over-quarter to $294M.

Based on Stokes Capital Advisors's 13F filing for Q1 2023, filed 12 Apr 2023.